RISPERIDONE | A077543 | CHARTWELL MOLECULAR HOLDINGS LLC
Highest NADAC/Unit
$0.0828
per ea
Lowest NADAC/Unit
$0.0355
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 62135060560RISPERIDONE 4 MG TABLET | $0.0828 | EA | Generic | — | 2026-06-17 |
| 62135060460RISPERIDONE 3 MG TABLET | $0.0686 | EA | Generic | — | 2026-06-17 |
| 62135060360RISPERIDONE 2 MG TABLET | $0.0513 | EA | Generic | — | 2026-06-17 |
| 62135060260RISPERIDONE 1 MG TABLET | $0.0385 | EA | Generic | — | 2026-06-17 |
| 62135060060RISPERIDONE 0.25 MG TABLET | $0.0358 | EA | Generic | — | 2026-06-17 |
| 62135060160RISPERIDONE 0.5 MG TABLET | $0.0355 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.